Quick Answer
OCULAR THERAPEUTIX, INC reported Operating Income Loss of -$270.02 million for the year ending 2025.
- OCULAR THERAPEUTIX, INC showed a decrease of -57.2% in Operating Income Loss from 2024 to 2025.
- This data is from OCULAR THERAPEUTIX, INC's annual report (Form 10-K), filed with the SEC on February 5, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), OCULAR THERAPEUTIX, INC's Operating Income Loss has declined by 1,875.1%.
- Historical annual values: Fiscal year 2025: -$270.02 million | Fiscal year 2024: -$171.78 million | Fiscal year 2023: -$82.38 million | Fiscal year 2022: -$78.65 million | Fiscal year 2021: -$78.04 million | Fiscal year 2020: -$62.85 million | Fiscal year 2019: -$85.80 million | Fiscal year 2018: -$59.12 million | Fiscal year 2017: -$61.92 million | Fiscal year 2016: -$43.33 million | Fiscal year 2015: -$38.20 million | Fiscal year 2014: -$27.09 million | Fiscal year 2013: -$12.90 million | Fiscal year 2012: -$13.67 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: